Peramivir

(1s,2s,3r,4r)-3-((1s)-1-acetylamino-2-ethylbutyl))-4-((aminoiminomethyl)amino)-2-hydroxycyclopentane, (1S,2S,3R,4R)-3-((1S)-1-acetylamino-2-ethylbutyl))-4-((aminoiminomethyl)amino-2-hydroxycyclopentanecarboxylic acid, trihydrate, 3-(1'-acetylamino-2'-ethyl)butyl-4-((aminoimino)methyl)amino-2-hydroxycyclopentane-1-carboxylic acid, BCX 1812, BCX-1812, BCX1812, Peramivir, Rapiacta, RWJ 270201, RWJ-270201, RWJ270201, UNII-9ZS94HQO3B, UNII-QW7Y7ZR15U, (1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethyl-butyl]-4- (diaminomethylideneamino)-2-hydroxy-cyclopentane- 1-carboxylic acid

Peramivir is  classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
SMILES:   CCC(CC)[C,,H]([C,H]1[C,,H](C[C,,H]([C,H]1O)C(=O)O)NC(=N)N)NC(=O)C